Matthew Faber

Company: Xencor

Job title: Senior Scientist

Seminars:

Preclinical Showcase of XmAb541 in Claudin 6-Targeted Bispecific Antibody Therapy 9:30 am

• Showcasing Xencor’s XmAb541, a CLDN6 x CD3 bispecific antibody, designed to engage T cells and selectively kill claudin 6 expressing tumor cells while sparing normal tissues • Uncovering preclinical data, focusing on safety, tolerability, and preliminary efficacy against ovarian cancer and other solid tumors • Outlining future development plans, including combination strategies with other…Read more

day: Conference Day 1